Garden supplier Hozelock introduces hygienic and non-invasive smart fingerprints for drug testing to help keep staff safe
NEW YORK, Jan. 31, 2023 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”) today announced that global garden equipment manufacturer Hozelock is implementing drug testing using sweat-based fingerprint technology becomes the company’s subsidiary, Intelligent Fingerprinting, to promote employee safety. Hozelock will use the sweat-based fingerprint drug test to determine recent use of cocaine, cannabis, methamphetamine or opioids by employees.
The Intelligent Fingerprinting platform, which analyzes sweat to detect recent drug use, is fast, hygienic and non-invasive, allowing Hozelock HR staff to easily conduct drug testing when needed. As Hozelock’s headcount varies based on seasonal demand, ranging from 320 to around 650, our fingerprint testing technology makes testing particularly convenient when staff resources are limited.
Because the smart fingerprint system is wearable and visible, conducting on-site drug testing is also a great way to promote Hozelock’s drug use policy to new employees and potential employees. Hozelock had consulted with Unite, his union, prior to implementing the change and received full support for the new testing system.
Andrew Parker, Hozelock’s Human Resources Manager, said: “Smart fingerprinting is a really good way to enable us to conduct random drug testing in-house – a process that is an important contributor to Hozelock’s excellent safety record. We first consulted with Unite, who fully supported our use of fingerprint-based drug screening. Compared to urine and saliva methods, the fingerprint method of drug testing treats the employee with much more dignity, while the system’s shorter detection window means we don’t invade our employees’ privacy.”
“Nobody in HR ever wants to catch someone with a drug test. But some of our operations are potentially dangerous, and as a responsible employer, it’s important that we do the right things to protect our employees and their colleagues. However, as a team, we are only concerned with ensuring employees can work safely for their shift – not what they may have been doing over the weekend. With its detection window of less than 24 hours, the Intelligent Fingerprinting system allows us to pay close attention to ensure the security of our employees while respecting their privacy during their free time. In our experience, traditional testing typically looks for excess drug use, and that is not what health and safety drug testing is about,” continued Mr. Parker.
Harry Simeonidis, President and CEO of Intelligent Bio Solutions added, “Employees in safety-critical manufacturing areas who are under the influence of medication can pose a hazard to both themselves and their colleagues. The introduction of a simple, reliable and portable fingerprint drug test demonstrates an organization’s commitment to health and safety and its clear support of union policy of treating employees with dignity. For this reason, Intelligent Fingerprinting is the best method for drug testing compared to traditional urine and saliva-based methods.”
Fingerprint-based drug test – this is how it works: The Intelligent Fingerprinting drug testing system features a small, tamper-resistant drug screening cartridge that collects ten fingerprint sweat samples in a process that takes less than a minute. The Intelligent Fingerprinting portable analyzer then reads the cartridge and within ten minutes provides a positive or negative result on the screen for any drug being tested.
About Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc. is a life sciences company that develops and delivers real-time, intelligent, non-invasive testing solutions to customers worldwide. With its world’s first biosensor platform, Intelligent Bio Solutions develops and commercializes diagnostic tests that are urgently needed to help people living with chronic diseases. In addition, through its recent acquisition of Intelligent Fingerprinting Limited, the company is a global leader in the advancement of portable drug testing through fingerprint sweat analysis. The system is a platform technology with potential applications in many areas of diagnostics. The advantages include non-invasive, hygienic, fast and inexpensive. Best selling product screens for recent use of most commonly used drugs at work; opioids, cocaine, methamphetamine and marijuana. Sampling takes only a few seconds, results in ten minutes. Customers include employers in safety-critical industries such as construction, transport and logistics companies, drug treatment organizations and UK coroners. A laboratory confirmation service is also available.
For more information, visit http://www.ibs.inc/
About intelligent fingerprints
Intelligent Fingerprinting’s wearable drug screening system works by analyzing fingerprint sweat. It is non-invasive, fast and inexpensive, with sample collection taking seconds and simultaneous screening for multiple drug groups in tens of minutes. A laboratory confirmation service is also available. The system has applications across many sectors and customers include employers in safety-critical industries such as construction, transport and logistics companies, drug treatment organizations and UK forensic pathologists. An introductory video demonstrating fingerprint-based drug testing in action is available here.
Intelligent Fingerprinting is a wholly owned subsidiary of Intelligent Bio Solutions Inc. (Nasdaq: INBS).
Hozelock is one of the UK’s most popular garden suppliers. Founded in 1959, the company’s first product was the Hoze-Lock – the world’s first plastic hose connector. Today the company is headquartered in Birmingham and 75% of Hozelock gardening tools are manufactured in the UK with the remaining 25% being manufactured in overseas factories in France, Malaysia, Taiwan and China. The company is part of the Exel Industries Group www.hozelock.com
Some of the statements in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Forward-looking statements in this press release include, without limitation, Intelligent Bio Solutions Inc.’s ability to complete the proposed transaction described in this press release, to develop and commercialize its diagnostic tests, to realize commercial benefits from its partnerships and collaborations, and to secure regulatory permits, among others. Although Intelligent Bio Solutions Inc. believes that the expectations reflected in such forward-looking statements are reasonable as of the date hereof, the expectations may differ materially from the results expressed or implied in such forward-looking statements. Intelligent Bio Solutions Inc. has attempted to identify forward-looking statements through terminology, including “believes,” “estimates,” “anticipates,” “expects,” “plans,” “projects,” “intends,” “potential,” “may.” ‘, ‘could’, ‘could’, ‘will’, ‘should’, ‘about’ or other words expressing uncertainty of future events or results to identify these forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties and other factors that are contained in Intelligent Bio Solutions’ public filings with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of their date. Intelligent Bio Solutions undertakes no obligation to update any forward-looking statements contained in this press release to reflect events or circumstances after their date or to reflect the occurrence of unanticipated events.
Smart Bio Solutions Inc.
KCSA Strategic Communication